Interestingly, our data, in line with previously published data on vascular microdialysis15, are close to the MARD of 10%, which is requested in diabetes care to enable non-adjunct continuous subcutaneous glucose monitoring for insulin dosing decisions and also fulfils criteria proposed for critical care (MARD < 14%)31. The gene discussed is INS; the disease is diabetes mellitus.